Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.62
+0.05 (0.76%)
At close: Jul 16, 2025, 4:00 PM
6.51
-0.11 (-1.66%)
After-hours: Jul 16, 2025, 6:34 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Medicines for Childhood and Adult Diseases with Equal Intensity
131.16M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
131.16M